Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-09-27
AEs
3
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild CHEST PAIN — outcome: RECOVERED/RESOLVED; onset 2013-10-10 (study day 14.0); relationship: REMOTE
moderate
assessed
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-21 (study day 25.0); relationship: POSSIBLE
moderate
assessed
Moderate PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-10-21 (study day 25.0); relationship: POSSIBLE
Data queries
No data queries.